Delayed-type hypersensitivity to vaccine aluminum adjuvant causing subcutaneous leg mass and urticaria in a child

Pediatr Dermatol. 2018 Mar;35(2):234-236. doi: 10.1111/pde.13390. Epub 2018 Jan 4.

Abstract

A 3-year-old girl presented with a 7-month history of a waxing and waning left thigh mass associated with pruritus and erythema at the site of two previous DTaP-HepB-IPV vaccinations. Patch testing was positive to aluminum chloride, supporting a diagnosis of vaccine granuloma secondary to aluminum allergy; her symptoms had been well controlled with antihistamines and topical steroids. Injection site granulomas are a benign but potentially bothersome reaction to aluminum-containing immunizations that can be supportively managed, and we encourage strict adherence to the recommended vaccine schedule in this setting. Patch testing is a sensitive, noninvasive diagnostic tool for patients presenting with this clinical finding, and dermatologist awareness can prevent unnecessary medical examination and provide reassurance.

Keywords: allergy; lumps/bumps; pruritus; therapy-topical; urticaria.

Publication types

  • Case Reports

MeSH terms

  • Aluminum Chloride
  • Aluminum Compounds / adverse effects*
  • Aluminum Compounds / immunology
  • Child, Preschool
  • Chlorides / adverse effects*
  • Chlorides / immunology
  • Female
  • Glucocorticoids / therapeutic use
  • Granuloma / drug therapy
  • Granuloma / etiology*
  • Histamine Antagonists / therapeutic use
  • Humans
  • Hypersensitivity, Delayed / diagnosis*
  • Hypersensitivity, Delayed / drug therapy
  • Hypersensitivity, Delayed / etiology
  • Leg / pathology
  • Patch Tests / methods
  • Urticaria / diagnosis*
  • Urticaria / drug therapy
  • Urticaria / etiology
  • Vaccination / adverse effects*

Substances

  • Aluminum Compounds
  • Chlorides
  • Glucocorticoids
  • Histamine Antagonists
  • Aluminum Chloride